Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report  
Delayed Quote. Delayed Nyse - 07/19 04:01:28 pm
87.49 USD   -0.31%
07/17CSX and Nu Skin fall while Abbott and Cintas rise
AQ
07/17Wall St. falls as CSX results signal damage from trade tensions
RE
07/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Abbott Laboratories : Launches Rapid Point-of-Care HbA1c Test to Aid in Diabetes Diagnosis

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/17/2019 | 08:42am EDT

By Michael Dabaie

Abbott Laboratories (ABT) said its Afinion HbA1c Dx assay is now available for use on the Afinion 2 Analyzer and Afinion AS100 Analyzer.

The Afinion HbA1c Dx assay is a rapid point-of-care test cleared by the U.S. Food and Drug Administration to aid healthcare professionals in the diagnosis of diabetes and the assessment of patients' risk of developing the condition.

The test delivers glycated hemoglobin, or HbA1c, results in three minutes, Abbott said.

Write to Michael Dabaie at michael.dabaie@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
07/17CSX and Nu Skin fall while Abbott and Cintas rise
AQ
07/17Wall St. falls as CSX results signal damage from trade tensions
RE
07/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/17ABBOTT LABORATORIES : hits record high as diabetes device fuels profit beat
RE
07/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/17GLOBAL MARKETS LIVE : BHP Group, Netflix, Amazon, LVMH…
07/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/17ABBOTT LABORATORIES : Raises Full-Year Guidance on Strong 2Q
DJ
07/17ABBOTT LABORATORIES : Reports Higher 2Q Profit, Sales
DJ
07/17ABBOTT : 2Q Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2019 31 968 M
EBIT 2019 7 161 M
Net income 2019 3 657 M
Debt 2019 12 277 M
Yield 2019 1,43%
P/E ratio 2019 39,9x
P/E ratio 2020 34,7x
EV / Sales2019 5,21x
EV / Sales2020 4,76x
Capitalization 154 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 93,08  $
Last Close Price 87,49  $
Spread / Highest target 25,7%
Spread / Average Target 6,38%
Spread / Lowest Target -20,0%
EPS Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Robert B. Ford President & Chief Operating Officer
Brian Bernard Yoor Chief Financial Officer & Executive VP-Finance
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES20.96%154 348
MASIMO CORPORATION42.87%8 185
ASAHI INTECC CO., LTD.-37.78%6 778
NOVOCURE LTD107.26%6 645
PENUMBRA INC44.14%6 119
GETINGE69.71%3 962